BDBM412194 US10398703, Compound 17::US10966987, Compound 17

SMILES CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OCCCN4CCC5(COC5)CC4)c(OC)cc23)cc1Cl

InChI Key InChIKey=SMTDQOKIICWYEE-UHFFFAOYSA-N

Data  2 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 412194   

TargetVascular endothelial growth factor receptor 2(Human)
Kala Pharmaceuticals

US Patent
LigandPNGBDBM412194(US10398703, Compound 17 | US10966987, Compound 17)
Affinity DataKd:  1.00E+3nMAssay Description:A VEGFR2 tagged T7 phage strain was prepared in an Escherichia coli (E. coli) derived from the BL21 strain. The E. coli were grown to log-phase, infe...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Kala Pharmaceuticals

US Patent
LigandPNGBDBM412194(US10398703, Compound 17 | US10966987, Compound 17)
Affinity DataKd:  1.00E+3nMAssay Description:A competition binding assay (DISCOVERX KINOMESCAN ) was used to measure the ability of a compound to compete for binding of an immobilized adenosine ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent